Showing results (51-60 of 318) with videos related to

Sort By:
Pageof 32
Cells|May 14, 2022
DNA Damage Response Inhibitors in Cholangiocarcinoma: Current Progress and PerspectivesÖykü Gönül Geyik, Giulia Anichini, Engin Ulukaya, et al.
Journal of Hepatology|May 20, 2022
Metabolic reprogramming in cholangiocarcinomaChiara Raggi, Maria Letizia Taddei, Colin Rae, et al.
Frontiers in Cell and Developmental Biology|January 24, 2025
Organoids and spheroids: advanced in vitro models for liver cancer researchMirella Pastore, Alessia Giachi, Elena Spínola-Lasso, et al.
Advances in Experimental Medicine and Biology|March 6, 2010
HIF-mediated hypoxic response is missing in severely hypoxic uterine leiomyomasArnulf Mayer, Michael Hoeckel, Angelika von Wallbrunn, et al.
Visceral Medicine|July 18, 2019
Excellent Response to Anti-PD-1 Therapy in a Patient with Hepatocellular Carcinoma Intolerant to SorafenibChristoph Roderburg, Marie-Luise Berres, Alexander Wree, et al.
International Journal of Molecular Sciences|July 19, 2020
In Vivo Models for Cholangiocarcinoma-What Can We Learn for Human Disease?Raphael Mohr, Burcin Özdirik, Jana Knorr, et al.
Quantitative Imaging in Medicine and Surgery|February 3, 2022
Shear wave elastography and shear wave dispersion imaging in primary biliary cholangitis-a pilot studyMarten Schulz, Anne-Christin B Wilde, Münevver Demir, et al.
Clinical and Experimental Medicine|June 17, 2015
Management strategies for hepatocellular carcinoma: old certainties and new realitiesGianluigi Mazzoccoli, Roberto Tarquini, Alice Valoriani, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 4, 2022
Preneoplastic lesions in the liver: Molecular insights and relevance for clinical practiceElvire Desjonqueres, Claudia Campani, Fabio Marra, et al.
Pageof 32